Literature DB >> 27051498

Multiple Retinal Vein Occlusions Associated with Anti-thrombin III Deficiency.

Ramin Nourinia1, Talie Montahaei1, Bahareh Behdad1, Ali Aghajani1.   

Abstract

Entities:  

Year:  2015        PMID： 27051498      PMCID： PMC4795403          DOI： 10.4103/2008-322X.176906

Source DB:  PubMed          Journal:  J Ophthalmic Vis Res        ISSN： 2008-322X


× No keyword cloud information.
  7 in total

Review 1.  Laboratory tests for antithrombin deficiency.

Authors:  Bernard Khor; Elizabeth M Van Cott
Journal:  Am J Hematol       Date:  2010-12       Impact factor: 10.047

2.  Heparin cofactor II deficiency in central retinal vein occlusion.

Authors:  L O Hattenbach; C Klais; I Scharrer
Journal:  Acta Ophthalmol Scand       Date:  1998-12

Review 3.  [Acquired antithrombin III deficiency].

Authors:  G Müller
Journal:  Z Gesamte Inn Med       Date:  1992-02

Review 4.  Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.

Authors:  S Kuhle; D A Lane; K Jochmanns; C Male; P Quehenberger; K Lechner; I Pabinger
Journal:  Thromb Haemost       Date:  2001-10       Impact factor: 5.249

5.  High prevalence of resistance to APC in young patients with retinal vein occlusion.

Authors:  Claudia Kuhli; Lars-Olof Hattenbach; Inge Scharrer; Frank Koch; Christian Ohrloff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-02-22       Impact factor: 3.117

6.  Central retinal vein prethrombosis as an initial manifestation of protein S deficiency.

Authors:  Paulo de Tarso Ponte Pierre-Filho; Alessandra Maria Mont'Alverne Pierre; Maurício Abujamra Nascimento; Ana Maria Marcondes
Journal:  Sao Paulo Med J       Date:  2004-09-16       Impact factor: 1.044

7.  Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.

Authors:  N J Beauchamp; R N Pike; M Daly; L Butler; M Makris; T R Dafforn; A Zhou; H L Fitton; F E Preston; I R Peake; R W Carrell
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.